Competition for targets, a tougher stance from regulators and uneven performance are likely to create an uneasy environment for healthcare special purpose acquisition companies in 2022, S&P Global reports. A total of 107 SPACs that listed parts of the healthcare industry as their intended target went public in 2021, according to S&P Global Market Intelligence data. Deal volume picked up in the last four months of the year, with 23 IPOs in November and December. That uptick in volume means more competition for healthcare companies that are mature enough to go public. Read more.
Related Posts
Nikola Sells Abandoned EV Pickup Truck Program to Friend of Convicted Founder
News of the deal to sell the Badger program comes just a few weeks after Nikola’s disgraced founder, Trevor Milton, announced plans to try to install Sparks and a slate of other directors on the company’s board. That effort failed.
Everton FC Takeover Plotted by SPAC Led by George Soros’ Nephew
LAMF Global Ventures I has reportedly held preliminary talks with the English Premier League football club about a deal.
Mortgage Lender Better Cuts a Quarter of its Workforce 2 Weeks After $500M SPAC Deal
When Better first announced plans to go public at a $7.7 billion valuation, it was a different time. Mortgage interest rates were lower, the housing market had not slowed so dramatically, and the company was coming off a year in which it claimed to have notched $500 million in profits.
SPAC Sponsors with $18B Face Deadline on What to Do Next
With investors increasingly asking for better terms to stick around, sponsors without automatic extensions will likely have to pay up to entice holders to stay — or close up shop and eat the roughly $8 million in fees they fronted.